IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
This study is currently recruiting participants.
Verified January 2017 by Alice S. Ryan, PhD, Baltimore VA Medical Center
Sponsor:
Baltimore VA Medical Center
Information provided by (Responsible Party):
Alice S. Ryan, PhD, Baltimore VA Medical Center
ClinicalTrials.gov Identifier:
NCT01302197
First received: February 23, 2011
Last updated: January 30, 2017
Last verified: January 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Stroke, a leading cause of disability in the aging population, increases the risk for diabetes, subsequent stroke recurrence, and cardiovascular disease complications. The downsizing of private and federal health care resources, along with the anticipated increase in stroke rates as our population ages, mandate that alternative strategies be developed to reduce the public health burden of stroke. This pilot study may facilitate our knowledge of the timing of paretic leg muscle atrophy, fiber type shift, and the progression of worsening of glucose tolerance after stroke. Knowledge of the skeletal muscle changes occurring in the sub-acute stroke period is essential to create new guidelines incorporating exercise rehabilitation, much like cardiac rehabilitation, in order to facilitate and improve the health care of veteran stroke survivors.
| Condition | Intervention |
|---|---|
| Stroke | Other: No intervention |
| Study Type: | Observational |
| Study Design: | Observational Model: Other Time Perspective: Prospective |
| Official Title: | Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke |
Further study details as provided by Alice S. Ryan, PhD, Baltimore VA Medical Center:
Primary Outcome Measures:
- Change in body composition [ Time Frame: change in muscle mass from baseline to 3 months ]Muscle mass
Secondary Outcome Measures:
- Change in glucose [ Time Frame: change in glucose from baseline to 3 months ]glucose levels
- Change in physical function [ Time Frame: change in walk distance from baseline to 3 months ]walk distance
Biospecimen Retention: Samples Without DNA
Blood samples will be analyzed for metabolic biomarkers. Muscle tissue is collected for measurements of muscle phenotype. A urine pregnancy test is performed in women of child bearing age before CT imaging to exclude pregnant women due to the risk to an unborn fetus.
| Estimated Enrollment: | 100 |
| Study Start Date: | September 2011 |
| Estimated Study Completion Date: | December 2018 |
| Estimated Primary Completion Date: | December 2017 (Final data collection date for primary outcome measure) |
Intervention Details:
Detailed Description:
-
Other: No intervention
longitudinal follow-up after stroke
The vast majority of cerebrovascular accidents are reported in persons older than 55 years of age and occur in over 780,000 persons each year in the U.S. As our adult population ages, the number of strokes in the United States is anticipated to double, reaching nearly 1.5 million annually by the year 2050. Following stroke, patients remain at continued high risk for recurrent stroke with almost a third of them suffering recurrent stroke within 5 years, even despite optimal medical management. Age and cardiac disease are among the most important longitudinal predictors of cardiovascular health outcomes and survival after stroke. Notably, 75% of chronic stroke survivors have residual disability emphasizing the need for rehabilitation strategies.
Knowledge of the skeletal muscle changes that occur in the early phases after stroke is essential to create new guidelines which incorporate exercise rehabilitation, much like cardiac rehabilitation, in order to facilitate and improve the health care of stroke survivors.
Eligibility| Ages Eligible for Study: | 21 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Acute Stroke
Criteria
Inclusion Criteria:
- Men or women 21 years of age or older
- BMI between 20-50 kg/m2
- Presenting within a month after stroke onset with residual hemiparetic deficit
- Patients must have adequate language and neurocognitive function to participate in testing and give adequate informed consent
Exclusion Criteria:
- Patients deemed too disabled to participate in physical therapy, or patients with minimal deficits, or patients who fully recovered after their stroke, in which physical therapy is not necessary
- Unstable angina, CHF, severe PAD
- Dementia or untreated major depression
- Severe receptive or global aphasia
- Heavy alcohol use defined by greater than 3 oz. liquor, 12 oz of wine or 32 oz of beer daily
-
Muscle biopsy Exclusion Criteria:
- anti-coagulation therapy with heparin, warfarin, or lovenox (anti-platelet therapy is permitted)
- bleeding disorder
- allergy to lidocaine
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01302197
Please refer to this study by its ClinicalTrials.gov identifier: NCT01302197
Contacts
| Contact: Alice Ryan, Ph.D. | 410-605-7851 | aryan@grecc.umaryland.edu |
Locations
| United States, Maryland | |
| University of Maryland Medical System | Recruiting |
| Baltimore, Maryland, United States, 21201 | |
| VA Maryland Health Care System, Baltimore | Recruiting |
| Baltimore, Maryland, United States, 21201 | |
| Contact: Emily Byrne Emily.Byrne@va.gov | |
| Kernan Hospital | Recruiting |
| Baltimore, Maryland, United States, 21207 | |
Sponsors and Collaborators
Baltimore VA Medical Center
Investigators
| Principal Investigator: | Alice S Ryan, Ph.D. | University of Maryland School of Medicine, Baltimore VA Research Service |
| Principal Investigator: | Charlene Hafer-Macko, M.D. | University of Maryland, VA Research Service, Department of Neurology |
More Information
| Responsible Party: | Alice S. Ryan, PhD, Professor of Medicine, Baltimore VA Medical Center |
| ClinicalTrials.gov Identifier: | NCT01302197 History of Changes |
| Other Study ID Numbers: |
HP-00042905 |
| Study First Received: | February 23, 2011 |
| Last Updated: | January 30, 2017 |
| Individual Participant Data | |
| Plan to Share IPD: | No |
Keywords provided by Alice S. Ryan, PhD, Baltimore VA Medical Center:
|
Stroke Body Composition Glucose Tolerance |
Additional relevant MeSH terms:
|
Stroke Atrophy Muscular Atrophy Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Vascular Diseases Cardiovascular Diseases Pathological Conditions, Anatomical Neuromuscular Manifestations Neurologic Manifestations Signs and Symptoms |
ClinicalTrials.gov processed this record on June 23, 2017